Skip to main content
Erschienen in: Pituitary 6/2015

01.12.2015

Surgery induced hypopituitarism in acromegalic patients: a systematic review and meta-analysis of the results

verfasst von: Pedro Carvalho, Eva Lau, Davide Carvalho

Erschienen in: Pituitary | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Hypopituitarism is a possible complication of the surgical treatment of acromegaly. However, there is a wide variability in the incidence rates of surgery-induced hypopituitarism. The purpose of this study was the systematic collection and synthesis of information on the incidence rates of hypopituitarism, panhypopituitarism, specific axis deficiencies and diabetes insipidus after surgery for acromegaly treatment.

Methods

We systematically reviewed all the papers that have reported pituitary deficits after surgery for acromegaly published up until December 2014, in the PubMed database. We identified 92 studies enrolling 6988 patients. A meta-analysis was performed to evaluate the incidence rates. We also performed several subgroup analyses to evaluate the impact of both surgical technique, and treatment prior to surgery, on the results.

Results

The weighted incidence rates were 12.79 % for hypopituitarism (95 % CI 9.88–16.00 %), 2.50 % for panhypopituitarism (95 % CI 1.24–4.15 %), 6.50 % for ACTH deficiency (95 % CI 4.07–9.44 %), 4.39 % for TSH deficiency (95 % CI 2.99–6.04 %), 6.70 % for FSH/LH deficiency (95 % CI 3.89–10.17 %), 14.95 % for GH deficiency (95 % CI 7.25–24.64 %), 10.05 % for transient (95 % CI 7.18–13.33 %) and 2.42 % for permanent diabetes insipidus (95 % CI 1.70–3.27 %).

Conclusion

Our study provides new data on the incidence rates of hypopituitarism, specific pituitary axis deficiencies and diabetes insipidus after surgical treatment of acromegaly. Somatotroph function appears to be more prone to deficit than the other axes. However, there is a high heterogeneity between studies and several factors may influence the incidence of hypopituitarism.
Literatur
3.
Zurück zum Zitat Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95(7):3141–3148. doi:10.1210/jc.2009-2670 PubMedCrossRef Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95(7):3141–3148. doi:10.​1210/​jc.​2009-2670 PubMedCrossRef
5.
Zurück zum Zitat Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D, Clemmons D, Chanson P, Laws E, Schlechte J, Vance ML, Ho K, Giustina A (2009) Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 94(5):1509–1517. doi:10.1210/jc.2008-2421 PubMedCrossRef Melmed S, Colao A, Barkan A, Molitch M, Grossman AB, Kleinberg D, Clemmons D, Chanson P, Laws E, Schlechte J, Vance ML, Ho K, Giustina A (2009) Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 94(5):1509–1517. doi:10.​1210/​jc.​2008-2421 PubMedCrossRef
11.
Zurück zum Zitat Neyeloff J, Fuchs S, Moreira L (2012) Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res Notes 5(1):52PubMedCentralPubMedCrossRef Neyeloff J, Fuchs S, Moreira L (2012) Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res Notes 5(1):52PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Inder WJ, Espiner EA, MacFarlane MR (2003) Outcome from surgical management of secretory pituitary adenomas in Christchurch. N Z Intern Med J 33(4):168–173CrossRef Inder WJ, Espiner EA, MacFarlane MR (2003) Outcome from surgical management of secretory pituitary adenomas in Christchurch. N Z Intern Med J 33(4):168–173CrossRef
14.
Zurück zum Zitat Kaplan FJ, Levitt NS, De Villiers JC, Soule SG (2001) Acromegaly in the developing world–a 20-year teaching hospital experience. Br J Neurosurg 15(1):22–27PubMedCrossRef Kaplan FJ, Levitt NS, De Villiers JC, Soule SG (2001) Acromegaly in the developing world–a 20-year teaching hospital experience. Br J Neurosurg 15(1):22–27PubMedCrossRef
15.
16.
Zurück zum Zitat Nomikos P, Buchfelder M, Fahlbusch R (2005) The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’. Eur J Endocrinol/Eur Fed Endocr Soc 152(3):379–387. doi:10.1530/eje.1.01863 CrossRef Nomikos P, Buchfelder M, Fahlbusch R (2005) The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’. Eur J Endocrinol/Eur Fed Endocr Soc 152(3):379–387. doi:10.​1530/​eje.​1.​01863 CrossRef
17.
Zurück zum Zitat Takahashi JA, Shimatsu A, Nakao K, Hashimoto N (2004) Early postoperative indicators of late outcome in acromegalic patients. Clin Endocrinol 60(3):366–374CrossRef Takahashi JA, Shimatsu A, Nakao K, Hashimoto N (2004) Early postoperative indicators of late outcome in acromegalic patients. Clin Endocrinol 60(3):366–374CrossRef
18.
Zurück zum Zitat Valdemarsson S, Bramnert M, Cronquist S, Elner A, Eneroth CM, Hedner P, Lindvall-Axelsson M, Nordstrom CH, Stromblad LG (1991) Early postoperative basal serum GH level and the GH response to TRH in relation to the long-term outcome of surgical treatment for acromegaly: a report on 39 patients. J Intern Med 230(1):49–54PubMedCrossRef Valdemarsson S, Bramnert M, Cronquist S, Elner A, Eneroth CM, Hedner P, Lindvall-Axelsson M, Nordstrom CH, Stromblad LG (1991) Early postoperative basal serum GH level and the GH response to TRH in relation to the long-term outcome of surgical treatment for acromegaly: a report on 39 patients. J Intern Med 230(1):49–54PubMedCrossRef
19.
Zurück zum Zitat van Lindert E, Hey O, Boecher-Schwarz H, Perneczky A (1997) Treatment results of acromegaly as analyzed by different criteria. Acta neurochirurgica 139(10): 905–912; discussion 912-903 van Lindert E, Hey O, Boecher-Schwarz H, Perneczky A (1997) Treatment results of acromegaly as analyzed by different criteria. Acta neurochirurgica 139(10): 905–912; discussion 912-903
20.
Zurück zum Zitat Van Rompaey K, Unuane D, Moens M, Duerinck J, Poppe K, Velkeniers B, D’Haens J (2013) Long-term follow-up results of multimodal treatment with initial surgical approach for acromegaly in a single center. Acta Neurol Belg 113(1):49–54. doi:10.1007/s13760-012-0128-8 PubMedCrossRef Van Rompaey K, Unuane D, Moens M, Duerinck J, Poppe K, Velkeniers B, D’Haens J (2013) Long-term follow-up results of multimodal treatment with initial surgical approach for acromegaly in a single center. Acta Neurol Belg 113(1):49–54. doi:10.​1007/​s13760-012-0128-8 PubMedCrossRef
23.
Zurück zum Zitat Attanasio R, Montini M, Valota M, Cortesi L, Barbo R, Biroli F, Tonnarelli G, Albizzi M, Testa RM, Pagani G (2008) An audit of treatment outcome in acromegalic patients attending our center at Bergamo, Italy. Pituitary 11(1):1–11. doi:10.1007/s11102-007-0059-1 PubMedCrossRef Attanasio R, Montini M, Valota M, Cortesi L, Barbo R, Biroli F, Tonnarelli G, Albizzi M, Testa RM, Pagani G (2008) An audit of treatment outcome in acromegalic patients attending our center at Bergamo, Italy. Pituitary 11(1):1–11. doi:10.​1007/​s11102-007-0059-1 PubMedCrossRef
24.
Zurück zum Zitat Arafah BU, Brodkey JS, Kaufman B, Velasco M, Manni A, Pearson OH (1980) Transsphenoidal microsurgery in the treatment of acromegaly and gigantism. J Clin Endocrinol Metab 50(3):578–585. doi:10.1210/jcem-50-3-578 PubMedCrossRef Arafah BU, Brodkey JS, Kaufman B, Velasco M, Manni A, Pearson OH (1980) Transsphenoidal microsurgery in the treatment of acromegaly and gigantism. J Clin Endocrinol Metab 50(3):578–585. doi:10.​1210/​jcem-50-3-578 PubMedCrossRef
25.
Zurück zum Zitat De P, Rees DA, Davies N, John R, Neal J, Mills RG, Vafidis J, Davies JS, Scanlon MF (2003) Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission. J Clin Endocrinol Metab 88(8):3567–3572. doi:10.1210/jc.2002-021822 PubMedCrossRef De P, Rees DA, Davies N, John R, Neal J, Mills RG, Vafidis J, Davies JS, Scanlon MF (2003) Transsphenoidal surgery for acromegaly in wales: results based on stringent criteria of remission. J Clin Endocrinol Metab 88(8):3567–3572. doi:10.​1210/​jc.​2002-021822 PubMedCrossRef
26.
Zurück zum Zitat Ludecke D, Kautzky R, Saeger W, Schrader D (1976) Selective removal of hypersecreting pituitary adenomas? An analysis of endocrine function, operative and microscopical findings in 101 cases. Acta Neurochir 35(1–3):27–42PubMedCrossRef Ludecke D, Kautzky R, Saeger W, Schrader D (1976) Selective removal of hypersecreting pituitary adenomas? An analysis of endocrine function, operative and microscopical findings in 101 cases. Acta Neurochir 35(1–3):27–42PubMedCrossRef
27.
Zurück zum Zitat Tucker HS, Grubb SR, Wigand JP, Watlington CO, Blackard WG, Becker DP (1980) The treatment of acromegaly by transsphenoidal surgery. Arch Intern Med 140(6):795–802PubMedCrossRef Tucker HS, Grubb SR, Wigand JP, Watlington CO, Blackard WG, Becker DP (1980) The treatment of acromegaly by transsphenoidal surgery. Arch Intern Med 140(6):795–802PubMedCrossRef
28.
Zurück zum Zitat Ahmed S, Elsheikh M, Stratton IM, Page RC, Adams CB, Wass JA (1999) Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol 50(5):561–567CrossRef Ahmed S, Elsheikh M, Stratton IM, Page RC, Adams CB, Wass JA (1999) Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol 50(5):561–567CrossRef
29.
Zurück zum Zitat Ronchi CL, Giavoli C, Ferrante E, Verrua E, Bergamaschi S, Ferrari DI, Corbetta S, Montefusco L, Arosio M, Ambrosi B, Spada A, Beck-Peccoz P (2009) Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments. Eur J Endocrinol/Eur Fed Endocr Soc 161(1):37–42. doi:10.1530/eje-09-0222 CrossRef Ronchi CL, Giavoli C, Ferrante E, Verrua E, Bergamaschi S, Ferrari DI, Corbetta S, Montefusco L, Arosio M, Ambrosi B, Spada A, Beck-Peccoz P (2009) Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments. Eur J Endocrinol/Eur Fed Endocr Soc 161(1):37–42. doi:10.​1530/​eje-09-0222 CrossRef
31.
Zurück zum Zitat Rosen T, Bengtsson BA (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336(8710):285–288PubMedCrossRef Rosen T, Bengtsson BA (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336(8710):285–288PubMedCrossRef
36.
Zurück zum Zitat Ku CR, Kim EH, Oh MC, Lee EJ, Kim SH (2012) Surgical and endocrinological outcomes in the treatment of growth hormone-secreting pituitary adenomas according to the shift of surgical paradigm. Neurosurgery 71(2 Suppl Operative):192–203; discussion ons203 doi:10.1227/NEU.0b013e318265a288 Ku CR, Kim EH, Oh MC, Lee EJ, Kim SH (2012) Surgical and endocrinological outcomes in the treatment of growth hormone-secreting pituitary adenomas according to the shift of surgical paradigm. Neurosurgery 71(2 Suppl Operative):192–203; discussion ons203 doi:10.​1227/​NEU.​0b013e318265a288​
37.
Zurück zum Zitat Ciric I, Ragin A, Baumgartner C, Pierce D (1997) Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 40(2):225–236; discussion 236-227 Ciric I, Ragin A, Baumgartner C, Pierce D (1997) Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 40(2):225–236; discussion 236-227
38.
Zurück zum Zitat Kabil MS, Eby JB, Shahinian HK (2005) Fully endoscopic endonasal versus transseptal transsphenoidal pituitary surgery. Minim Invasive Neurosurg : MIN 48(6):348–354 doi:10.1055/s-2005-915635 Kabil MS, Eby JB, Shahinian HK (2005) Fully endoscopic endonasal versus transseptal transsphenoidal pituitary surgery. Minim Invasive Neurosurg : MIN 48(6):348–354 doi:10.​1055/​s-2005-915635
39.
Zurück zum Zitat Frank G, Pasquini E, Farneti G, Mazzatenta D, Sciarretta V, Grasso V, Faustini Fustini M (2006) The endoscopic versus the traditional approach in pituitary surgery. Neuroendocrinology 83(3–4):240–248. doi:10.1159/000095534 PubMedCrossRef Frank G, Pasquini E, Farneti G, Mazzatenta D, Sciarretta V, Grasso V, Faustini Fustini M (2006) The endoscopic versus the traditional approach in pituitary surgery. Neuroendocrinology 83(3–4):240–248. doi:10.​1159/​000095534 PubMedCrossRef
40.
43.
Zurück zum Zitat Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357(9254):425–431PubMedCrossRef Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357(9254):425–431PubMedCrossRef
44.
Zurück zum Zitat Yamada S, Fukuhara N, Nishioka H, Takeshita A, Suzuki H, Miyakawa M, Takeuchi Y (2011) GH deficiency in patients after cure of acromegaly by surgery alone. Eur J Endocrinol/Eur Fed Endocr Soc 165(6):873–879. doi:10.1530/eje-11-0657 CrossRef Yamada S, Fukuhara N, Nishioka H, Takeshita A, Suzuki H, Miyakawa M, Takeuchi Y (2011) GH deficiency in patients after cure of acromegaly by surgery alone. Eur J Endocrinol/Eur Fed Endocr Soc 165(6):873–879. doi:10.​1530/​eje-11-0657 CrossRef
46.
Zurück zum Zitat Abe T, Ludecke DK (1999) Recent primary transnasal surgical outcomes associated with intraoperative growth hormone measurement in acromegaly. Clin Endocrinol 50(1):27–35CrossRef Abe T, Ludecke DK (1999) Recent primary transnasal surgical outcomes associated with intraoperative growth hormone measurement in acromegaly. Clin Endocrinol 50(1):27–35CrossRef
47.
Zurück zum Zitat Abe T, Ludecke DK (2001) Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre. Eur J Endocrinol/Eur Fed Endocr Soc 145(2):137–145CrossRef Abe T, Ludecke DK (2001) Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre. Eur J Endocrinol/Eur Fed Endocr Soc 145(2):137–145CrossRef
48.
Zurück zum Zitat Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 83(10):3411–3418. doi:10.1210/jcem.83.10.5111 PubMedCrossRef Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 83(10):3411–3418. doi:10.​1210/​jcem.​83.​10.​5111 PubMedCrossRef
49.
Zurück zum Zitat Atkinson RL, Becker DP, Martins AN, Schaaf M, Dimond RC, Wartofsky L, Earll JM (1975) Acromegaly. Treatment by transsphenoidal microsurgery. JAMA 233(12):1279–1283PubMedCrossRef Atkinson RL, Becker DP, Martins AN, Schaaf M, Dimond RC, Wartofsky L, Earll JM (1975) Acromegaly. Treatment by transsphenoidal microsurgery. JAMA 233(12):1279–1283PubMedCrossRef
52.
Zurück zum Zitat Berkmann S, Fandino J, Muller B, Kothbauer KF, Henzen C, Landolt H (2012) Pituitary surgery: experience from a large network in Central Switzerland. Swiss Med Wkly 142:w13680. doi:10.4414/smw.2012.13680 PubMed Berkmann S, Fandino J, Muller B, Kothbauer KF, Henzen C, Landolt H (2012) Pituitary surgery: experience from a large network in Central Switzerland. Swiss Med Wkly 142:w13680. doi:10.​4414/​smw.​2012.​13680 PubMed
53.
Zurück zum Zitat Biermasz NR, van Dulken H, Roelfsema F (1999) Direct postoperative and follow-up results of transsphenoidal surgery in 19 acromegalic patients pretreated with octreotide compared to those in untreated matched controls. J Clin Endocrinol Metab 84(10):3551–3555. doi:10.1210/jcem.84.10.6027 PubMedCrossRef Biermasz NR, van Dulken H, Roelfsema F (1999) Direct postoperative and follow-up results of transsphenoidal surgery in 19 acromegalic patients pretreated with octreotide compared to those in untreated matched controls. J Clin Endocrinol Metab 84(10):3551–3555. doi:10.​1210/​jcem.​84.​10.​6027 PubMedCrossRef
55.
Zurück zum Zitat Bourdelot A, Coste J, Hazebroucq V, Gaillard S, Cazabat L, Bertagna X, Bertherat J (2004) Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly. Eur J Endocrinol/Eur Fed Endoc Soc 150(6):763–771CrossRef Bourdelot A, Coste J, Hazebroucq V, Gaillard S, Cazabat L, Bertagna X, Bertherat J (2004) Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly. Eur J Endocrinol/Eur Fed Endoc Soc 150(6):763–771CrossRef
56.
Zurück zum Zitat Burgers AM, Kokshoorn NE, Pereira AM, Roelfsema F, Smit JW, Biermasz NR, Romijn JA (2011) Low incidence of adrenal insufficiency after transsphenoidal surgery in patients with acromegaly: a long-term follow-up study. J Clin Endocrinol Metab 96(7):E1163–E1170. doi:10.1210/jc.2010-2673 PubMedCrossRef Burgers AM, Kokshoorn NE, Pereira AM, Roelfsema F, Smit JW, Biermasz NR, Romijn JA (2011) Low incidence of adrenal insufficiency after transsphenoidal surgery in patients with acromegaly: a long-term follow-up study. J Clin Endocrinol Metab 96(7):E1163–E1170. doi:10.​1210/​jc.​2010-2673 PubMedCrossRef
57.
58.
Zurück zum Zitat Cappabianca P, Alfieri A, Colao A, Ferone D, Lombardi G, de Divitiis E (1999) Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions. Skull Base Surg 9(2):109–117PubMedCentralPubMedCrossRef Cappabianca P, Alfieri A, Colao A, Ferone D, Lombardi G, de Divitiis E (1999) Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions. Skull Base Surg 9(2):109–117PubMedCentralPubMedCrossRef
59.
Zurück zum Zitat Chandna A, Islam N, Jabbar A, Zuberi L, Haque N (2004) Clinical features and outcome of surgery in 30 patients with acromegaly. JPMA J Pak Med Assoc 54(6):315–319PubMed Chandna A, Islam N, Jabbar A, Zuberi L, Haque N (2004) Clinical features and outcome of surgery in 30 patients with acromegaly. JPMA J Pak Med Assoc 54(6):315–319PubMed
60.
Zurück zum Zitat Colao A, Attanasio R, Pivonello R, Cappabianca P, Cavallo LM, Lasio G, Lodrini A, Lombardi G, Cozzi R (2006) Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J Clin Endocrinol Metab 91(1):85–92. doi:10.1210/jc.2005-1208 PubMedCrossRef Colao A, Attanasio R, Pivonello R, Cappabianca P, Cavallo LM, Lasio G, Lodrini A, Lombardi G, Cozzi R (2006) Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J Clin Endocrinol Metab 91(1):85–92. doi:10.​1210/​jc.​2005-1208 PubMedCrossRef
61.
Zurück zum Zitat Colao A, Cappabianca P, Caron P, De Menis E, Farrall AJ, Gadelha MR, Hmissi A, Rees A, Reincke M, Safari M, T’Sjoen G, Bouterfa H, Cuneo RC (2009) Octreotide LAR versus surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study. Clin Endocrinol 70(5):757–768. doi:10.1111/j.1365-2265.2008.03441.x CrossRef Colao A, Cappabianca P, Caron P, De Menis E, Farrall AJ, Gadelha MR, Hmissi A, Rees A, Reincke M, Safari M, T’Sjoen G, Bouterfa H, Cuneo RC (2009) Octreotide LAR versus surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study. Clin Endocrinol 70(5):757–768. doi:10.​1111/​j.​1365-2265.​2008.​03441.​x CrossRef
62.
Zurück zum Zitat Conceicao FL, Fisker S, Andersen M, Kaal A, Jorgensen JO, Vaisman M, Christiansen JS (2003) Evaluation of growth hormone stimulation tests in cured acromegalic patients. Growth Horm & IGF Res 13(6):347–352CrossRef Conceicao FL, Fisker S, Andersen M, Kaal A, Jorgensen JO, Vaisman M, Christiansen JS (2003) Evaluation of growth hormone stimulation tests in cured acromegalic patients. Growth Horm & IGF Res 13(6):347–352CrossRef
63.
64.
Zurück zum Zitat Dusek T, Kastelan D, Melada A, Baretic M, Polovina TS, Perkovic Z, Giljevic Z, Jelcic J, Paladino J, Aganovic I, Korsic M (2011) Clinical features and therapeutic outcomes of patients with acromegaly: single-center experience. J Endocrinol Investig 34(11):e382–e385. doi:10.3275/7858 Dusek T, Kastelan D, Melada A, Baretic M, Polovina TS, Perkovic Z, Giljevic Z, Jelcic J, Paladino J, Aganovic I, Korsic M (2011) Clinical features and therapeutic outcomes of patients with acromegaly: single-center experience. J Endocrinol Investig 34(11):e382–e385. doi:10.​3275/​7858
66.
Zurück zum Zitat Fujio S, Tokimura H, Hirano H, Hanaya R, Kubo F, Yunoue S, Bohara M, Kinoshita Y, Tominaga A, Arimura H, Arita K (2013) Severe growth hormone deficiency is rare in surgically-cured acromegalics. Pituitary 16(3):326–332. doi:10.1007/s11102-012-0424-6 PubMedCentralPubMed Fujio S, Tokimura H, Hirano H, Hanaya R, Kubo F, Yunoue S, Bohara M, Kinoshita Y, Tominaga A, Arimura H, Arita K (2013) Severe growth hormone deficiency is rare in surgically-cured acromegalics. Pituitary 16(3):326–332. doi:10.​1007/​s11102-012-0424-6 PubMedCentralPubMed
67.
Zurück zum Zitat Fukuda I, Hizuka N, Murakami Y, Itoh E, Yasumoto K, Sata A, Takano K (2001) Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women’s Medical University. Intern Med (Tokyo, Japan) 40(10):987–992CrossRef Fukuda I, Hizuka N, Murakami Y, Itoh E, Yasumoto K, Sata A, Takano K (2001) Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women’s Medical University. Intern Med (Tokyo, Japan) 40(10):987–992CrossRef
68.
Zurück zum Zitat Geelhoed-Duijvestijn PH, Bussemaker JK, Roelfsema F (1989) Changes in basal and stimulated TSH and other parameters of thyroid function in acromegaly after transsphenoidal surgery. Acta Endocrinol 121(2):207–215PubMed Geelhoed-Duijvestijn PH, Bussemaker JK, Roelfsema F (1989) Changes in basal and stimulated TSH and other parameters of thyroid function in acromegaly after transsphenoidal surgery. Acta Endocrinol 121(2):207–215PubMed
69.
Zurück zum Zitat Gittoes NJ, Sheppard MC, Johnson AP, Stewart PM (1999) Outcome of surgery for acromegaly–the experience of a dedicated pituitary surgeon. QJM : Mon J Assoc Physicians 92(12):741–745CrossRef Gittoes NJ, Sheppard MC, Johnson AP, Stewart PM (1999) Outcome of surgery for acromegaly–the experience of a dedicated pituitary surgeon. QJM : Mon J Assoc Physicians 92(12):741–745CrossRef
70.
Zurück zum Zitat Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T (2010) Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Neurosurg Focus 29(4):E7. doi:10.3171/2010.7.focus10167 PubMedCrossRef Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T (2010) Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Neurosurg Focus 29(4):E7. doi:10.​3171/​2010.​7.​focus10167 PubMedCrossRef
71.
Zurück zum Zitat Greenman Y, Tordjman K, Kisch E, Razon N, Ouaknine G, Stern N (1995) Relative sparing of anterior pituitary function in patients with growth hormone-secreting macroadenomas: comparison with nonfunctioning macroadenomas. J Clin Endocrinol Metab 80(5):1577–1583. doi:10.1210/jcem.80.5.7745003 PubMed Greenman Y, Tordjman K, Kisch E, Razon N, Ouaknine G, Stern N (1995) Relative sparing of anterior pituitary function in patients with growth hormone-secreting macroadenomas: comparison with nonfunctioning macroadenomas. J Clin Endocrinol Metab 80(5):1577–1583. doi:10.​1210/​jcem.​80.​5.​7745003 PubMed
72.
Zurück zum Zitat Grisoli F, Leclercq T, Jaquet P, Guibout M, Winteler JP, Hassoun J, Vincentelli F (1985) Transsphenoidal surgery for acromegaly–long-term results in 100 patients. Surg Neurol 23(5):513–519PubMedCrossRef Grisoli F, Leclercq T, Jaquet P, Guibout M, Winteler JP, Hassoun J, Vincentelli F (1985) Transsphenoidal surgery for acromegaly–long-term results in 100 patients. Surg Neurol 23(5):513–519PubMedCrossRef
73.
Zurück zum Zitat Hazer DB, Isik S, Berker D, Guler S, Gurlek A, Yucel T, Berker M (2013) Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria. J Neurosurg 119(6):1467–1477. doi:10.3171/2013.8.jns13224 PubMedCrossRef Hazer DB, Isik S, Berker D, Guler S, Gurlek A, Yucel T, Berker M (2013) Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria. J Neurosurg 119(6):1467–1477. doi:10.​3171/​2013.​8.​jns13224 PubMedCrossRef
74.
Zurück zum Zitat Hensen J, Henig A, Fahlbusch R, Meyer M, Boehnert M, Buchfelder M (1999) Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas. Clin Endocrinol 50(4):431–439CrossRef Hensen J, Henig A, Fahlbusch R, Meyer M, Boehnert M, Buchfelder M (1999) Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas. Clin Endocrinol 50(4):431–439CrossRef
75.
77.
Zurück zum Zitat Jaffrain-Rea ML, Minniti G, Moroni C, Esposito V, Ferretti E, Santoro A, Infusino T, Tamburrano G, Cantore G, Cassone R (2003) Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly. Eur J Endocrinol/Eur Fed Endocr Soc 148(2):193–201CrossRef Jaffrain-Rea ML, Minniti G, Moroni C, Esposito V, Ferretti E, Santoro A, Infusino T, Tamburrano G, Cantore G, Cassone R (2003) Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly. Eur J Endocrinol/Eur Fed Endocr Soc 148(2):193–201CrossRef
78.
Zurück zum Zitat Jakobsson KE, Petruson B, Elfverson J, Bengtsson BA (1995) Results of the lateral rhinotomy approach in transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma. Br J Neurosurg 9(6):763–768PubMedCrossRef Jakobsson KE, Petruson B, Elfverson J, Bengtsson BA (1995) Results of the lateral rhinotomy approach in transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma. Br J Neurosurg 9(6):763–768PubMedCrossRef
79.
Zurück zum Zitat Jane JA Jr, Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO, Marshall JC, Laws ER Jr, Vance ML (2011) Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab 96(9):2732–2740. doi:10.1210/jc.2011-0554 PubMedCrossRef Jane JA Jr, Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO, Marshall JC, Laws ER Jr, Vance ML (2011) Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab 96(9):2732–2740. doi:10.​1210/​jc.​2011-0554 PubMedCrossRef
80.
Zurück zum Zitat Karaca Z, Tanriverdi F, Elbuken G, Cakir I, Donmez H, Selcuklu A, Durak AC, Dokmetas HS, Colak R, Unluhizarci K, Kelestimur F (2011) Comparison of primary octreotide-lar and surgical treatment in newly diagnosed patients with acromegaly. Clin Endocrinol 75(5):678–684. doi:10.1111/j.1365-2265.2011.04106.x CrossRef Karaca Z, Tanriverdi F, Elbuken G, Cakir I, Donmez H, Selcuklu A, Durak AC, Dokmetas HS, Colak R, Unluhizarci K, Kelestimur F (2011) Comparison of primary octreotide-lar and surgical treatment in newly diagnosed patients with acromegaly. Clin Endocrinol 75(5):678–684. doi:10.​1111/​j.​1365-2265.​2011.​04106.​x CrossRef
81.
Zurück zum Zitat Kawamata T, Kubo O, Hori T (2005) Surgical removal of growth hormone-secreting pituitary adenomas with intensive microsurgical pseudocapsule resection results in complete remission of acromegaly. Neurosurg Rev 28(3):201–208. doi:10.1007/s10143-005-0384-7 PubMedCrossRef Kawamata T, Kubo O, Hori T (2005) Surgical removal of growth hormone-secreting pituitary adenomas with intensive microsurgical pseudocapsule resection results in complete remission of acromegaly. Neurosurg Rev 28(3):201–208. doi:10.​1007/​s10143-005-0384-7 PubMedCrossRef
83.
Zurück zum Zitat Kristof RA, Stoffel-Wagner B, Klingmuller D, Schramm J (1999) Does octreotide treatment improve the surgical results of macro-adenomas in acromegaly? A randomized study. Acta Neurochir 141(4):399–405PubMedCrossRef Kristof RA, Stoffel-Wagner B, Klingmuller D, Schramm J (1999) Does octreotide treatment improve the surgical results of macro-adenomas in acromegaly? A randomized study. Acta Neurochir 141(4):399–405PubMedCrossRef
84.
Zurück zum Zitat Ku CR, Hong JW, Kim EH, Kim SH, Lee EJ (2014) Clinical predictors of GH deficiency in surgically cured acromegalic patients. Eur J Endocrinol/Eur Fed Endocr Soc 171(3):379–387. doi:10.1530/eje-14-0304 CrossRef Ku CR, Hong JW, Kim EH, Kim SH, Lee EJ (2014) Clinical predictors of GH deficiency in surgically cured acromegalic patients. Eur J Endocrinol/Eur Fed Endocr Soc 171(3):379–387. doi:10.​1530/​eje-14-0304 CrossRef
85.
Zurück zum Zitat Kurosaki M, Luedecke DK, Abe T (2003) Effectiveness of secondary transnasal surgery in GH-secreting pituitary macroadenomas. Endocr J 50(5):635–642PubMedCrossRef Kurosaki M, Luedecke DK, Abe T (2003) Effectiveness of secondary transnasal surgery in GH-secreting pituitary macroadenomas. Endocr J 50(5):635–642PubMedCrossRef
86.
Zurück zum Zitat Lampropoulos KI, Samonis G, Nomikos P (2013) Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients. Hormones (Athens, Greece) 12(2):254–264CrossRef Lampropoulos KI, Samonis G, Nomikos P (2013) Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients. Hormones (Athens, Greece) 12(2):254–264CrossRef
87.
Zurück zum Zitat Li ZQ, Quan Z, Tian HL, Cheng M (2012) Preoperative lanreotide treatment improves outcome in patients with acromegaly resulting from invasive pituitary macroadenoma. J Int Med Res 40(2):517–524PubMedCrossRef Li ZQ, Quan Z, Tian HL, Cheng M (2012) Preoperative lanreotide treatment improves outcome in patients with acromegaly resulting from invasive pituitary macroadenoma. J Int Med Res 40(2):517–524PubMedCrossRef
88.
Zurück zum Zitat Losa M, Mortini P, Urbaz L, Ribotto P, Castrignano T, Giovanelli M (2006) Presurgical treatment with somatostatin analogs in patients with acromegaly: effects on the remission and complication rates. J Neurosurg 104(6):899–906. doi:10.3171/jns.2006.104.6.899 PubMedCrossRef Losa M, Mortini P, Urbaz L, Ribotto P, Castrignano T, Giovanelli M (2006) Presurgical treatment with somatostatin analogs in patients with acromegaly: effects on the remission and complication rates. J Neurosurg 104(6):899–906. doi:10.​3171/​jns.​2006.​104.​6.​899 PubMedCrossRef
89.
Zurück zum Zitat Maric A, Kruljac I, Cerina V, Pecina HI, Sulentic P, Vrkljan M (2012) Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a Croatian referral pituitary center experience. Croat Med J 53(3):224–233PubMedCentralPubMedCrossRef Maric A, Kruljac I, Cerina V, Pecina HI, Sulentic P, Vrkljan M (2012) Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a Croatian referral pituitary center experience. Croat Med J 53(3):224–233PubMedCentralPubMedCrossRef
90.
Zurück zum Zitat Minniti G, Jaffrain-Rea ML, Esposito V, Santoro A, Moroni C, Lenzi J, Tamburrano G, Cassone R, Cantore G (2001) Surgical treatment and clinical outcome of GH-secreting adenomas in elderly patients. Acta Neurochir 143(12):1205–1211. doi:10.1007/s007010100015 PubMedCrossRef Minniti G, Jaffrain-Rea ML, Esposito V, Santoro A, Moroni C, Lenzi J, Tamburrano G, Cassone R, Cantore G (2001) Surgical treatment and clinical outcome of GH-secreting adenomas in elderly patients. Acta Neurochir 143(12):1205–1211. doi:10.​1007/​s007010100015 PubMedCrossRef
91.
Zurück zum Zitat Minniti G, Moroni C, Jaffrain-Rea ML, Esposito V, Santoro A, Affricano C, Cantore G, Tamburrano G, Cassone R (2001) Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients. Clin Endocrinol 55(3):307–313CrossRef Minniti G, Moroni C, Jaffrain-Rea ML, Esposito V, Santoro A, Affricano C, Cantore G, Tamburrano G, Cassone R (2001) Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients. Clin Endocrinol 55(3):307–313CrossRef
92.
Zurück zum Zitat Mukherjee JJ, de Castro JJ, Kaltsas G, Afshar F, Grossman AB, Wass JA, Besser GM (1997) A comparison of the insulin tolerance/glucagon test with the short ACTH stimulation test in the assessment of the hypothalamo-pituitary-adrenal axis in the early post-operative period after hypophysectomy. Clin Endocrinol 47(1):51–60CrossRef Mukherjee JJ, de Castro JJ, Kaltsas G, Afshar F, Grossman AB, Wass JA, Besser GM (1997) A comparison of the insulin tolerance/glucagon test with the short ACTH stimulation test in the assessment of the hypothalamo-pituitary-adrenal axis in the early post-operative period after hypophysectomy. Clin Endocrinol 47(1):51–60CrossRef
93.
Zurück zum Zitat Murray RD, Peacey SR, Rahim A, Toogood AA, Thorner MO, Shalet SM (2001) The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients. Clin Endocrinol 54(1):37–44CrossRef Murray RD, Peacey SR, Rahim A, Toogood AA, Thorner MO, Shalet SM (2001) The diagnosis of growth hormone deficiency (GHD) in successfully treated acromegalic patients. Clin Endocrinol 54(1):37–44CrossRef
94.
Zurück zum Zitat Osman IA, James RA, Chatterjee S, Mathias D, Kendall-Taylor P (1994) Factors determining the long-term outcome of surgery for acromegaly. QJM : Mon J Assoc Physicians 87(10):617–623 Osman IA, James RA, Chatterjee S, Mathias D, Kendall-Taylor P (1994) Factors determining the long-term outcome of surgery for acromegaly. QJM : Mon J Assoc Physicians 87(10):617–623
95.
Zurück zum Zitat Oyen WJ, Pieters GF, Meijer E, Laarhoven JV, Smals AG, Kloppenborg PW (1988) Which factors predict the results of pituitary surgery in acromegaly? Acta Endocrinol 117(4):491–496 Oyen WJ, Pieters GF, Meijer E, Laarhoven JV, Smals AG, Kloppenborg PW (1988) Which factors predict the results of pituitary surgery in acromegaly? Acta Endocrinol 117(4):491–496
96.
Zurück zum Zitat Pekic S, Doknic M, Miljic D, Joksimovic M, Glodic J, Djurovic M, Dieguez C, Casanueva F, Popovic V (2006) Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly. Eur J Endocrinol/Eur Fed Endocr Soc 154(5):659–666. doi:10.1530/eje.1.02148 CrossRef Pekic S, Doknic M, Miljic D, Joksimovic M, Glodic J, Djurovic M, Dieguez C, Casanueva F, Popovic V (2006) Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly. Eur J Endocrinol/Eur Fed Endocr Soc 154(5):659–666. doi:10.​1530/​eje.​1.​02148 CrossRef
97.
Zurück zum Zitat Plockinger U, Quabbe HJ (2005) Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study. Acta Neurochir 147(5):485–493; discussion 493 (2005). doi:10.1007/s00701-005-0511-9 Plockinger U, Quabbe HJ (2005) Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study. Acta Neurochir 147(5):485–493; discussion 493 (2005). doi:10.​1007/​s00701-005-0511-9
98.
Zurück zum Zitat Quabbe HJ (1982) Treatment of acromegaly by trans-sphenoidal operation, 90-yttrium implantation and bromocriptine: results in 230 patients. Clin Endocrinol 16(2):107–119CrossRef Quabbe HJ (1982) Treatment of acromegaly by trans-sphenoidal operation, 90-yttrium implantation and bromocriptine: results in 230 patients. Clin Endocrinol 16(2):107–119CrossRef
99.
Zurück zum Zitat Roelfsema F, van Dulken H, Frolich M (1985) Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients. Clin Endocrinol 23(5):555–565CrossRef Roelfsema F, van Dulken H, Frolich M (1985) Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients. Clin Endocrinol 23(5):555–565CrossRef
100.
Zurück zum Zitat Ronchi CL, Ferrante E, Rizzo E, Giavoli C, Verrua E, Bergamaschi S, Lania AG, Beck-Peccoz P, Spada A (2008) Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients. Clin Endocrinol 69(4):608–612. doi:10.1111/j.1365-2265.2008.03270.x CrossRef Ronchi CL, Ferrante E, Rizzo E, Giavoli C, Verrua E, Bergamaschi S, Lania AG, Beck-Peccoz P, Spada A (2008) Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients. Clin Endocrinol 69(4):608–612. doi:10.​1111/​j.​1365-2265.​2008.​03270.​x CrossRef
102.
Zurück zum Zitat Sala E, Ferrante E, Locatelli M, Rampini P, Mantovani G, Giavoli C, Filopanti M, Verrua E, Malchiodi E, Carrabba G, Arosio M, Beck-Peccoz P, Spada A, Lania AG (2014) Diagnostic features and outcome of surgical therapy of acromegalic patients: experience of the last three decades. Hormones (Athens) 13(1):95–103 Sala E, Ferrante E, Locatelli M, Rampini P, Mantovani G, Giavoli C, Filopanti M, Verrua E, Malchiodi E, Carrabba G, Arosio M, Beck-Peccoz P, Spada A, Lania AG (2014) Diagnostic features and outcome of surgical therapy of acromegalic patients: experience of the last three decades. Hormones (Athens) 13(1):95–103
103.
Zurück zum Zitat Sheaves R, Jenkins P, Blackburn P, Huneidi AH, Afshar F, Medbak S, Grossman AB, Besser GM, Wass JA (1996) Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Clin Endocrinol 45(4):407–413CrossRef Sheaves R, Jenkins P, Blackburn P, Huneidi AH, Afshar F, Medbak S, Grossman AB, Besser GM, Wass JA (1996) Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Clin Endocrinol 45(4):407–413CrossRef
104.
Zurück zum Zitat Shin SS, Tormenti MJ, Paluzzi A, Rothfus WE, Chang YF, Zainah H, Fernandez-Miranda JC, Snyderman CH, Challinor SM, Gardner PA (2013) Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission. Pituitary 16(4):435–444. doi:10.1007/s11102-012-0440-6 PubMedCrossRef Shin SS, Tormenti MJ, Paluzzi A, Rothfus WE, Chang YF, Zainah H, Fernandez-Miranda JC, Snyderman CH, Challinor SM, Gardner PA (2013) Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission. Pituitary 16(4):435–444. doi:10.​1007/​s11102-012-0440-6 PubMedCrossRef
106.
Zurück zum Zitat Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA Jr (2013) Endoscopic versus microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. J Clin Endocrinol Metab 98(8):3190–3198. doi:10.1210/jc.2013-1036 PubMedCrossRef Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA Jr (2013) Endoscopic versus microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. J Clin Endocrinol Metab 98(8):3190–3198. doi:10.​1210/​jc.​2013-1036 PubMedCrossRef
107.
Zurück zum Zitat Sun H, Brzana J, Yedinak CG, Gultekin SH, Delashaw JB, Fleseriu M (2014) Factors associated with biochemical remission after microscopic transsphenoidal surgery for acromegaly. J Neurol Surg Part B Skull Base 75(1):47–52. doi:10.1055/s-0033-1354578 CrossRef Sun H, Brzana J, Yedinak CG, Gultekin SH, Delashaw JB, Fleseriu M (2014) Factors associated with biochemical remission after microscopic transsphenoidal surgery for acromegaly. J Neurol Surg Part B Skull Base 75(1):47–52. doi:10.​1055/​s-0033-1354578 CrossRef
108.
Zurück zum Zitat Swearingen B, Barker FG 2nd, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83(10):3419–3426. doi:10.1210/jcem.83.10.5222 PubMed Swearingen B, Barker FG 2nd, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83(10):3419–3426. doi:10.​1210/​jcem.​83.​10.​5222 PubMed
109.
Zurück zum Zitat Teasdale GM, Hay ID, Beasttall GH, McCruden DC, Thomson JA, Davies DL, Grossart KW, Ratcliffe JG (1982) Cryosurgery or microsurgery in the management of acromegaly. JAMA 247(9):1289–1291PubMedCrossRef Teasdale GM, Hay ID, Beasttall GH, McCruden DC, Thomson JA, Davies DL, Grossart KW, Ratcliffe JG (1982) Cryosurgery or microsurgery in the management of acromegaly. JAMA 247(9):1289–1291PubMedCrossRef
111.
Zurück zum Zitat Valdemarsson S, Ljunggren S, Bramnert M, Norrhamn O, Nordstrom CH (2000) Early postoperative growth hormone levels: high predictive value for long-term outcome after surgery for acromegaly. J Intern Med 247(6):640–650PubMedCrossRef Valdemarsson S, Ljunggren S, Bramnert M, Norrhamn O, Nordstrom CH (2000) Early postoperative growth hormone levels: high predictive value for long-term outcome after surgery for acromegaly. J Intern Med 247(6):640–650PubMedCrossRef
112.
Zurück zum Zitat van Bunderen CC, van Varsseveld NC, Baayen JC, van Furth WR, Aliaga ES, Hazewinkel MJ, Majoie CB, Freling NJ, Lips P, Fliers E, Bisschop PH, Drent ML (2013) Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging. Pituitary 16(2):158–167. doi:10.1007/s11102-012-0395-7 PubMedCentralPubMedCrossRef van Bunderen CC, van Varsseveld NC, Baayen JC, van Furth WR, Aliaga ES, Hazewinkel MJ, Majoie CB, Freling NJ, Lips P, Fliers E, Bisschop PH, Drent ML (2013) Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging. Pituitary 16(2):158–167. doi:10.​1007/​s11102-012-0395-7 PubMedCentralPubMedCrossRef
113.
Zurück zum Zitat van’t Verlaat JW, Nortier JW, Hendriks MJ, Bosma NJ, Graamans K, Lubsen H, Vasen HF, Thijssen JH, Croughs RJ (1988) Transsphenoidal microsurgery as primary treatment in 25 acromegalic patients: results and follow-up. Acta Endocrinol 117(2):154–158PubMed van’t Verlaat JW, Nortier JW, Hendriks MJ, Bosma NJ, Graamans K, Lubsen H, Vasen HF, Thijssen JH, Croughs RJ (1988) Transsphenoidal microsurgery as primary treatment in 25 acromegalic patients: results and follow-up. Acta Endocrinol 117(2):154–158PubMed
114.
115.
Zurück zum Zitat Wang YY, Higham C, Kearney T, Davis JR, Trainer P, Gnanalingham KK (2012) Acromegaly surgery in Manchester revisited–the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission. Clin Endocrinol 76(3):399–406. doi:10.1111/j.1365-2265.2011.04193.x CrossRef Wang YY, Higham C, Kearney T, Davis JR, Trainer P, Gnanalingham KK (2012) Acromegaly surgery in Manchester revisited–the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission. Clin Endocrinol 76(3):399–406. doi:10.​1111/​j.​1365-2265.​2011.​04193.​x CrossRef
116.
Zurück zum Zitat Yamada S, Takada K, Ozawa Y, Shimizu T, Sawano S, Shishiba Y, Sano T, Usui M (1997) The results of transsphenoidal surgery for 44 consecutive acromegalic patients. Endocr J 44(3):395–402PubMedCrossRef Yamada S, Takada K, Ozawa Y, Shimizu T, Sawano S, Shishiba Y, Sano T, Usui M (1997) The results of transsphenoidal surgery for 44 consecutive acromegalic patients. Endocr J 44(3):395–402PubMedCrossRef
117.
Zurück zum Zitat Zada G, Cavallo LM, Esposito F, Fernandez-Jimenez JC, Tasiou A, De Angelis M, Cafiero T, Cappabianca P, Laws ER (2010) Transsphenoidal surgery in patients with acromegaly: operative strategies for overcoming technically challenging anatomical variations. Neurosurg Focus 29(4):E8. doi:10.3171/2010.8.focus10156 PubMedCrossRef Zada G, Cavallo LM, Esposito F, Fernandez-Jimenez JC, Tasiou A, De Angelis M, Cafiero T, Cappabianca P, Laws ER (2010) Transsphenoidal surgery in patients with acromegaly: operative strategies for overcoming technically challenging anatomical variations. Neurosurg Focus 29(4):E8. doi:10.​3171/​2010.​8.​focus10156 PubMedCrossRef
Metadaten
Titel
Surgery induced hypopituitarism in acromegalic patients: a systematic review and meta-analysis of the results
verfasst von
Pedro Carvalho
Eva Lau
Davide Carvalho
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 6/2015
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-015-0661-6

Weitere Artikel der Ausgabe 6/2015

Pituitary 6/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.